B7-h3/cd276 inhibitors: is there room for the treatment of metastatic non-small cell lung cancer?

HIGHLIGHTS

  • who: Umberto Malapelle and collaborators from the Department of Public Health, University of Naples Federico II, Via SPansini, Naples, Italy have published the article: B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer?, in the Journal: (JOURNAL)
  • what: The striking clinical outcomes of antibody-based immunotherapy through the inhibitors of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and the programmed cell death protein-1 (PD-1) and its ligand (PD-L1) axis have driven research aimed at identifying further clinically relevant tumor antigens that can serve . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?